Healthcare provider profile · identity verified

Frank A. Gregory, MD

General Practice · LUQUILLO, PR · NPI 1063471480

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	581	124
Losartan Potassium	Losartan Potassium	420	90
Amlodipine Besylate	Amlodipine Besylate	341	79
Famotidine	Famotidine	303	52
Levothyroxine Sodium	Levothyroxine Sodium	280	45
Gabapentin	Gabapentin	253	41
Farxiga	Dapagliflozin Propanediol	216	40
Rosuvastatin Calcium	Rosuvastatin Calcium	187	43
Metoprolol Succinate	Metoprolol Succinate	180	37
Calcitriol	Calcitriol	171	36
Ezetimibe	Ezetimibe	166	36
Lisinopril	Lisinopril	161	26
Alendronate Sodium	Alendronate Sodium	133	24
Finasteride	Finasteride	131	31
Omeprazole	Omeprazole	127	20
Xigduo Xr	Dapaglifloz Propaned/Metformin	114	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	106	24
Synthroid	Levothyroxine Sodium	105	13
Tamsulosin Hcl	Tamsulosin Hcl	99	20
Montelukast Sodium	Montelukast Sodium	98	15
Pentoxifylline	Pentoxifylline	98	23
Glipizide Er	Glipizide	94	16
Furosemide	Furosemide	83	21
Metformin Hcl Er	Metformin Hcl	80	22
Lantus	Insulin Glargine,hum.Rec.Anlog	79	suppressed
Metformin Hcl	Metformin Hcl	79	15
Spironolactone	Spironolactone	79	13
Clopidogrel	Clopidogrel Bisulfate	74	12
Pantoprazole Sodium	Pantoprazole Sodium	70	15
Simvastatin	Simvastatin	70	15
Diclofenac Sodium	Diclofenac Sodium	67	37
Trijardy Xr	Empaglifloz/Linaglip/Metformin	61	suppressed
Trazodone Hcl	Trazodone Hcl	59	15
Carvedilol	Carvedilol	57	15
Tizanidine Hcl	Tizanidine Hcl	54	38
Irbesartan	Irbesartan	49	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	49	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	48	12
Sertraline Hcl	Sertraline Hcl	47	suppressed
Sucralfate	Sucralfate	47	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	44	suppressed
Ibandronate Sodium	Ibandronate Sodium	43	suppressed
Fluticasone Propionate	Fluticasone Propionate	41	11
Metoprolol Tartrate	Metoprolol Tartrate	41	suppressed
Propranolol Hcl	Propranolol Hcl	40	suppressed
Chlorthalidone	Chlorthalidone	37	11
Candesartan Cilexetil	Candesartan Cilexetil	36	suppressed
Lansoprazole	Lansoprazole	36	suppressed
Enalapril Maleate	Enalapril Maleate	34	suppressed
Tradjenta	Linagliptin	34	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	33	12
Desloratadine	Desloratadine	32	11
Donepezil Hcl	Donepezil Hcl	31	suppressed
Ramipril	Ramipril	31	suppressed
Glipizide Xl	Glipizide	30	suppressed
Baclofen	Baclofen	29	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	29	suppressed
Atenolol	Atenolol	28	suppressed
Eliquis	Apixaban	28	suppressed
Buspirone Hcl	Buspirone Hcl	27	suppressed
Candesartan-Hydrochlorothiazid	Candesartan/Hydrochlorothiazid	27	suppressed
Folic Acid	Folic Acid	27	suppressed
Glipizide	Glipizide	25	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	24	suppressed
Albuterol Sulfate	Albuterol Sulfate	23	18
Fluconazole	Fluconazole	23	14
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	23	suppressed
Jardiance	Empagliflozin	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	20	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	19	13
Duloxetine Hcl	Duloxetine Hcl	19	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	19	suppressed
Methotrexate	Methotrexate Sodium	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	14
Tolterodine Tartrate Er	Tolterodine Tartrate	17	suppressed
Dutasteride	Dutasteride	16	suppressed
Glyxambi	Empagliflozin/Linagliptin	16	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	16	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	15	suppressed
Entresto	Sacubitril/Valsartan	15	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	15	suppressed
Methylprednisolone	Methylprednisolone	15	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	14	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Prednisolone Sodium Phosphate	Prednisolone Sodium Phosphate	14	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Isosorbide Mononitrate	Isosorbide Mononitrate	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Prednisolone	Prednisolone	13	11
Synjardy	Empagliflozin/Metformin Hcl	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Allopurinol	Allopurinol	11	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Azithromycin	Azithromycin	11	suppressed
Ciclopirox	Ciclopirox	11	suppressed
Cromolyn Sodium	Cromolyn Sodium	11	suppressed
Dilantin	Phenytoin Sodium Extended	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Jentadueto	Linagliptin/Metformin Hcl	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Lovaza	Omega-3 Acid Ethyl Esters	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Repatha Sureclick	Evolocumab	11	suppressed
Rivastigmine	Rivastigmine	11	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error